Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2873877 | The Annals of Thoracic Surgery | 2013 | 6 Pages |
Abstract
A CMR on postinduction positron emission tomography scan predicts but should not be assumed to be synonymous with complete pathologic response in esophageal cancer patients. The presence of residual disease should be strongly considered despite CMR and negative biopsy in patients receiving induction therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Brendon M. MD, Gregory MD, Anna BS, Abu MS, Subroto MD, Paul C. MD, Jeffrey L. MD, Nasser K. MD,